Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Per Nørgaard is active.

Publication


Featured researches published by Per Nørgaard.


Journal of Biological Chemistry | 2011

Structural and Biological Properties of the Drosophila Insulin-Like Peptide 5 Show Evolutionary Conservation.

Waseem Sajid; Nikolaj Kulahin; Gerd Schluckebier; Ulla Ribel; Hope R. Henderson; Marc Tatar; Bo Falck Hansen; Angela Manegold Svendsen; Vladislav V. Kiselyov; Per Nørgaard; Per-Olof Wahlund; Jakob Brandt; Ronald A. Kohanski; Asser Sloth Andersen; Pierre De Meyts

We report the crystal structure of two variants of Drosophila melanogaster insulin-like peptide 5 (DILP5) at a resolution of 1.85 Å. DILP5 shares the basic fold of the insulin peptide family (T conformation) but with a disordered B-chain C terminus. DILP5 dimerizes in the crystal and in solution. The dimer interface is not similar to that observed in vertebrates, i.e. through an anti-parallel β-sheet involving the B-chain C termini but, in contrast, is formed through an anti-parallel β-sheet involving the B-chain N termini. DILP5 binds to and activates the human insulin receptor and lowers blood glucose in rats. It also lowers trehalose levels in Drosophila. Reciprocally, human insulin binds to the Drosophila insulin receptor and induces negative cooperativity as in the human receptor. DILP5 also binds to insect insulin-binding proteins. These results show high evolutionary conservation of the insulin receptor binding properties despite divergent insulin dimerization mechanisms.


Applied Microbiology and Biotechnology | 2013

Modulating heterologous protein production in yeast: the applicability of truncated auxotrophic markers

Ali Kazemi Seresht; Per Nørgaard; Eva Palmqvist; Asser Sloth Andersen; Lisbeth Olsson

The use of auxotrophic Saccharomyces cerevisiae strains for improved production of a heterologous protein was examined. Two different marker genes were investigated, encoding key enzymes in the metabolic pathways for amino acid (LEU2) and pyrimidine (URA3) biosynthesis, respectively. Expression plasmids, carrying the partly defective selection markers LEU2d and URA3d, were constructed. Two CEN.PK-derived strains were chosen and insulin analogue precursor was selected as a model protein. Different truncations of the LEU2 and URA3 promoters were used as the mean to titrate the plasmid copy number and thus the recombinant gene dosage in order to improve insulin productivity. Experiments were initially carried out in batch mode to examine the stability of yeast transformants and to select high yielding mutants. Next, chemostat cultivations were run at high cell density to address industrial applicability and long-term expression stability of the transformants. We found that the choice of auxotrophic marker is crucial for developing a yeast expression system with stable heterologous protein production. The incremental truncation of the URA3 promoter led to higher plasmid copy numbers and IAP yields, whereas the truncation of the LEU2 promoter caused low plasmid stability. We show that the modification of the level of the recombinant gene dosage by varying the degree of promoter truncation can be a strong tool for optimization of productivity. The application of the URA3d-based expression systems showed a high potential for industrial protein production and for further academic studies.


Yeast | 2003

Gene regulation in response to protein disulphide isomerase deficiency

Per Nørgaard; Christine Tachibana; Anette W. Bruun; Jakob R. Winther

We have examined the activities of promoters of a number of yeast genes encoding resident endoplasmic reticulum proteins, and found increased expression in a strain with severe protein disulphide isomerase deficiency. Serial deletion in the promoter of the MPD1 gene, which encodes a PDI1‐homologue, revealed a cis‐acting element responding to deficiency of protein disulphide isomerase activity (designated CERP). The presence of the sequence element is necessary and sufficient for the upregulation in response to disulphide isomerase deficiency, as measured by a minimal promoter containing the CERP element. The sequence (GACACG) does not resemble the unfolded protein response element. It is present in the upstream regions of the MPD1, MPD2, KAR2, PDI1 and ERO1 genes. Copyright


Journal of Cell Biology | 2001

Functional Differences in Yeast Protein Disulfide Isomerases

Per Nørgaard; Vibeke Westphal; Christine Tachibana; Lene Alsøe; Bjørn Holst; Jakob R. Winther


Analytical Biochemistry | 2007

Quantification of protein thiols and dithiols in the picomolar range using sodium borohydride and 4,4′-dithiodipyridine

Rosa E. Hansen; Henrik Østergaard; Per Nørgaard; Jakob R. Winther


Archive | 2007

Protease resistant insulin analogues

Peter Kresten Nielsen; Frantisek Hubalek; Inger Lautrup-Larsen; Svend Ludvigsen; Ulla Ribel-Madsen; Per Balschmidt; Per Nørgaard; Svend Havelund


Biochemical Journal | 2001

Mutation of yeast Eug1p CXXS active sites to CXXC results in a dramatic increase in protein disulphide isomerase activity.

Per Nørgaard; Jakob R. Winther


Archive | 2007

Method for making maturated insulin polypeptides

Per Nørgaard; Andersen Asser Sloth


Archive | 2010

METHOD FOR MAKING POLYPEPTIDES

Asser Sloth Andersen; Inger Lautrup-Larsen; Per Nørgaard


Archive | 2007

METHOD OF MAKING ACTIVATED CARBOXYPEPTIDASES

Per Nørgaard

Collaboration


Dive into the Per Nørgaard's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge